Belvedere Trading’s Hims & Hers Health HIMS Stock Holding History

Belvedere Trading’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,240	Closed	-$467K	–	933
2025 Q3	$467K	Sell	8,240 -20,995	-72%	-$1.08M	﹤0.01%	277
2025 Q2	$1.46M	Buy	+29,235	New	+$1.32M	﹤0.01%	114
2025 Q1	–	Sell	-6,520	Closed	-$158K	–	797
2024 Q4	$158K	Buy	+6,520	New	+$162K	﹤0.01%	457

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Belvedere Trading's HIMS Position: Q4 2025 in Review

Belvedere Trading sold out of Hims & Hers Health (HIMS) in Q4 2025, closing a stake of 8,240 shares — an estimated $467K sold.

Belvedere Trading first reported a position in HIMS in Q4 2024 and held it in 3 quarters. The position peaked at $1.46M in Q2 2025. 486 funds tracked by Wall St. Rank hold HIMS as of Q4 2025.

Belvedere Trading reported no remaining Hims & Hers Health position as of Q4 2025 after selling out during the quarter.
Belvedere Trading sold 8,240 Hims & Hers Health shares in Q4 2025, an estimated $467K.
Belvedere Trading first reported a position in Hims & Hers Health in Q4 2024 and held it in 3 quarters.
Belvedere Trading's Hims & Hers Health position peaked at $1.46M in Q2 2025.
486 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2025.

Based on Belvedere Trading's 13F filing for Q4 2025, filed 10 Feb 2026.